Literature DB >> 6600309

Splenic embolization to prevent dose limitation of cancer chemotherapy.

J Lokich, P Costello.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600309     DOI: 10.2214/ajr.140.1.159

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  5 in total

1.  Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes.

Authors:  Xiao-Ping Chen; Zhi-Yong Huang
Journal:  Langenbecks Arch Surg       Date:  2005-05-04       Impact factor: 3.445

2.  Surgical treatment of hepatocellular carcinoma with cirrhotic esophageal varices and hypersplenism: a 184 case report.

Authors:  Bin Jiang; Xiaoping Chen; Zhiyong Huang; Zhiwei Zhang; Songqing He; Shaofa Wang; Zaide Wu; Fazu Qiu
Journal:  Front Med China       Date:  2007-02-01

3.  Partial splenic embolization in the treatment of prolonged thrombocytopenia due to hypersplenism in metastatic cancer patients.

Authors:  Maria Passhak; Shlomit Strulov Shachar; Amos Ofer; Alexander Beny
Journal:  Support Care Cancer       Date:  2018-04-26       Impact factor: 3.603

4.  Partial splenic embolization with Glubran®2/Lipiodol® mixture for oncological patients with hypersplenism-related thrombocytopenia requiring systemic chemotherapy.

Authors:  Romaric Loffroy; Nicolas Falvo; Motoki Nakaï; Lorenzo Pescatori; Serge Aho-Gléglé; Sophie Gehin; Pierre-Emmanuel Berthod; Romaric Né; Julie Vincent; François Ghiringhelli; Marco Midulla; Olivier Chevallier
Journal:  Quant Imaging Med Surg       Date:  2019-03

5.  Partial Splenic Embolization as a Bridge to Total Knee Replacement for a Patient with Severe Thrombocytopenia due to Cirrhosis and Splenic Sequestration.

Authors:  Adrianne Netterville; Ronald Lands
Journal:  Case Rep Hematol       Date:  2012-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.